Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy

Seojin Lee1, Ivan Martinez-Valbuena2, Anthony E Lang3

  • 1Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario M5T 0S8, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

PubMed
Abstract

Insights

Multiple system atrophy (MSA) involves iron buildup in specific brain cells, differing between MSA subtypes. This cellular iron vulnerability pattern helps distinguish MSA-P and MSA-C, informing targeted therapies.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Iron Metabolism

Background:

  • Multiple system atrophy (MSA) is a neurodegenerative disease linked to iron accumulation in the brain.
  • The precise role of iron dysregulation in MSA pathogenesis and its relation to alpha-synuclein pathology remain unclear.
  • Understanding iron dysregulation at a cellular level is crucial for deciphering MSA.

Purpose of the Study:

  • To map iron burden in subcortical and brainstem regions in human MSA brains.
  • To conduct the first cell type-specific evaluation of pathological iron deposition in MSA.
  • To compare iron deposition patterns between MSA subtypes (MSA-P and MSA-C).

Main Methods:

  • Histological mapping of iron burden in post-mortem brains from MSA patients.
  • Cell type-specific iron evaluation using iron staining and immunolabelling in key brain regions.
  • Analysis of gene expression for iron- and oxygen-homeostatic genes in MSA cases.

Main Results:

  • Distinct regional iron burden patterns were observed between MSA-P and MSA-C subtypes.
  • Subcortical microglia predominantly accumulated iron, particularly in MSA-P; astroglia showed more heterogeneous accumulation in MSA-C.
  • Cellular iron burden was associated with oligodendroglial, not neuronal, alpha-synuclein pathology; gene expression revealed oxygen homeostasis dysregulation.

Conclusions:

  • Distinct regional and cellular iron distribution patterns were identified in MSA-P and MSA-C.
  • Cellular vulnerability to iron deposition serves as a novel neuropathological characteristic predicting MSA clinical subtypes.
  • Findings suggest distinct iron-related pathomechanisms in MSA subtypes, informing targeted iron chelation therapies.